BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MassBioEd Life Sciences Career Hub - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://careerhub.massbioed.org
X-WR-CALDESC:Events for MassBioEd Life Sciences Career Hub
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250915T090000
DTEND;TZID=America/New_York:20251002T113000
DTSTAMP:20250915T224423Z
CREATED:20250704T144418Z
LAST-MODIFIED:20250915T224423Z
UID:3050-1757926800-1759404600@careerhub.massbioed.org
SUMMARY:Intro to Biotech – Business and Science – Sept 2025
DESCRIPTION:Members of LabOps Unite\, please register here.\nMembers of Bio CT\, please register here.\nPlease view the discount options for courses before registering here.\n\n\nIntro to Biotech Package Member: $1\,550  \n\n\nIntro to Biotech Package Non-Member: 1\,800 \n\n\nMember Rate: $850 \n\n\nNon-Member Rate: $1\,025 \n\n\nInterested in offering the training exclusively to a group of your employees? Email courses@massbioed.org to learn more. \nDescription \nIntro to Biotech is a course that explores the business considerations in biotech as well as basic biological processes that are foundational to the biopharma and life sciences industry. The course is divided into two parts: Intro to Business and Intro to Science. Intro to Business provides an overview of regulation through instruction\, storytelling\, and small group sessions. Topics such as market share\, phases of development\, patient population\, and safety profile will be reviewed. Intro to Science focuses on the basics of cells and molecular biology that help students’ overall understanding of how a life science company operates. Lab work will also be implemented during in-person sessions. \n\n\nSchedule\nIntro to Business \n\nMonday\, September 15th\, 9:00 AM-11:30 AM EST\nWednesday\, September 17th\, 2025\, 9:00 AM-11:30 AM EST\nFriday\, September 19\, 2025\, 9:00 AM-11:30 AM EST\n\nIntro to Science \n\nMonday\, September 29th\, 2025\, 9:00 AM – 11:30 AM EST \nWednesday\, October 1st\, 2025\, 9:00 AM – 11:30 AM EST \nThursday\, October 2nd\, 2025\, 9:00 AM – 11:30 AM EST\n\n\n\n\n\nInstructors\n\nJohn Tagliamonte\nChief Executive Officer\, Mellitus\nBusiness \n\n\nJohn Tagliamonte has more than 30 years of experience in executive leadership with responsibility for business development\, finance\, commercial and business operations\, strategic planning\, finance and legal functions with established and emerging public and private life sciences companies.  As the first Entrepreneur-in-Residence with MassBio\, he was responsible for forward-looking program content across the organization\, while helping to develop the next generation of biotech entrepreneurs. He currently serves on the business advisory boards of therapeutic startups WntRx\, Fractal\, MarkTx\, PhagePro and Tantu.  Previously he led business development at Juniper\, was Chief Business Officer of Oxyrane and held various executive business leadership roles at Anchor Therapeutics\, ImmunoGen and Johnson & Johnson\, as well as venture investing with Safeguard.  He began his career as a scientist at Dana-Farber Cancer Institute followed by global business unit management at Bio-Rad.  Mr. Tagliamonte received his M.B.A. from Boston College and his B.S. in molecular biology from Tufts University. \n\n\n\n\nAtul Deshpande\, Ph.D.\, MBA\nChief Strategy Officer\, Peptilogics\nBusiness\nAtul Deshpande is the Chief Strategy Officer at Peptilogics\, a clinical stage AI/ML driven peptide therapeutics company\, where he is responsible for corporate strategy and business development. Prior to that he was the Chief Executive Officer of IMMEDIATE Therapeutics\, a clinical stage biotech company dedicated to developing safe and effective therapeutic solutions to reduce heart muscle damage and prevent cardiac arrest in Acute Coronary Syndromes (ACS)\, the most common cause of death and morbidity across the world. Atul spent 3 years in China as the Head of Asia Pacific R&D strategy to bring the global portfolio to China with minimal drug lag. Before Sanofi\, Atul worked as a management consultant for 9 years on projects across the value chain of pharma. Atul holds a Ph.D. from UC Irvine in Neuroscience and a post-doc from UCLA. \n\n\nSowmya Chary\, MD\, MMSc\nAssociate Medical Director\, Global Medical Safety and R&D\, Biogen\nScience\n \n\n\nSowmya is a Medical Director in Global Medical Safety at Biogen\, focusing in the Neuromuscular and Movement Disorders Therapeutic Area. A Massachusetts native\, she completed her medical training at Sri Ramachandra University in India and received her Master of Medical Sciences in Clinical Investigation from Harvard Medical School. She completed her thesis work at the Brigham and Women’s Hospital on sex-specific differences in metabolomic profiles and responses to intervention in the critically ill. Sowmya is a Fellow at the Harvard Medical School Center for Bioethics and serves on the Boston Board of Peer Health Exchange\, an organization improving health equity and outcomes for young people in under-resourced communities. She is a passionate educator and mentor and has given numerous talks on navigating career paths and roles in the biotechnology/pharmaceutical industry. She brings her medical\, research\, and industry expertise to the classroom to create an engaging and collaborative learning environment.
URL:https://careerhub.massbioed.org/event/intro-to-biotech-business-and-science-sept-2025/
LOCATION:Online Course\, United States
CATEGORIES:Industry Professionals
ATTACH;FMTTYPE=image/jpeg:https://careerhub.massbioed.org/wp-content/uploads/2025/03/green-header-2-7GvhOB.tmp_.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251007T100000
DTEND;TZID=America/New_York:20251010T123000
DTSTAMP:20251005T233049Z
CREATED:20250713T123432Z
LAST-MODIFIED:20251005T233049Z
UID:3207-1759831200-1760099400@careerhub.massbioed.org
SUMMARY:Finance of Biotech – October 2025
DESCRIPTION:Members of LabOps Unite\, please register here.\nMembers of Bio CT\, please register here.\nPlease view the discount options for courses before registering here.\n\n\nMember Rate: $925 \n\n\nNon-Member Rate: $1\,060 \n\n\nInterested in offering the training exclusively to a group of your employees? Email courses@massbioed.org to learn more. \nDescription\nThe Finance of Biotech focuses on various aspects of what’s needed for successful fundraising at each stage of company growth. The course addresses some of the common questions around risks of investing\, types of investment securities\, and differences between private and public markets. John Tagliamonte and Atul Deshpande\, CEO’s of biotech startups\, respectively\, will lead the course with invited guest lecturers from venture capital\, private equity\, investment banks\, and pharmaceutical companies. \n\nSchedule\n\nTuesday\, October 7th\, 2025\, 10:00 AM – 12:30 PM EST\nThursday\, October 9th\, 2025\, 10:00 AM – 12:30 PM EST\nFriday\, October 10th\, 2025\, 10:00 AM – 12:30 PM EST\n\nTopics\n\nPrimary Risks of Biotech Investing\nStarting with Debt and/or Stock Equity\, Major Stages of Startup Financing\nDilutive and Non-Dilutive Funding\nAssessing Your Company’s Value\nCommon Types of Investment Securities\n\nInstructors\nJohn Tagliamonte\nChief Executive Officer\, Mellitus\n \n\n\nJohn Tagliamonte has more than 20 years of experience in executive leadership with responsibility for business development\, finance\, commercial and business operations\, strategic planning\, finance and legal functions with established and emerging public and private life sciences companies.  As the first Entrepreneur-in-Residence with MassBio\, he was responsible for forward-looking program content across the organization\, while helping to develop the next generation of biotech entrepreneurs. He currently serves on the business advisory boards of therapeutic startups WntRx\, Fractal\, MarkTx\, PhagePro and Tantu.  Previously he led business development at Juniper\, was Chief Business Officer of Oxyrane and held various executive business leadership roles at Anchor Therapeutics\, ImmunoGen and Johnson & Johnson\, as well as venture investing with Safeguard.  He began his career as a scientist at Dana-Farber Cancer Institute followed by global business unit management at Bio-Rad.  Mr. Tagliamonte received his M.B.A. from Boston College and his B.S. in molecular biology from Tufts University. \nAtul Deshpande\, Ph.D.\, MBA\nChief Executive Officer\, IMMEDIATE Therapeutics \nAtul is the CEO of IMMEDIATE Therapeutics\, a clinical stage biotech company dedicated to developing safe and effective therapeutic solutions to reduce heart muscle damage and prevent cardiac arrest in Acute Coronary Syndromes (ACS)\, the most common cause of death and morbidity across the world. \nBefore joining IMMEDIATE Therapeutics\, Atul was the Chief Strategy Officer and Head\, US Operations of Harbour BioMed (HBM). Atul was primarily responsible for building the company’s short- and long-term strategy and portfolio along with a robust execution plan. In addition\, he is also accountable for the HBM’s operations in both the US and EU to maintain HBM’s footprint across these 2 very important markets\, along with managing key alliances in these regions. In 2020\, he contributed to raising 2 VC funding rounds and taking the company public in the HK stock exchange raising a total of $400M. \nBefore HBM\, Atul served as the Global Operations Head for the Dupixent Franchise with Sanofi. He led the operations\, including marketing\, market access\, supply chain\, to launch Dupixent in 52 markets across the world for Atopic Dermatitis and in major markets for Asthma. Prior to this\, he led the operations for Sanofi’s Immunology R&D portfolio and was also responsible for new product planning and in-licensing evaluations. He spent 3 years in China as the Head of Asia Pacific R&D strategy to bring the global portfolio to China with minimal drug lag. Before Sanofi\, Atul worked as a management consultant for 9 years on projects across the value chain of pharma.  \nAtul holds a Ph.D. from UC Irvine in Neuroscience and a post-doc from UCLA.
URL:https://careerhub.massbioed.org/event/finance-of-biotech-october-2025/
LOCATION:Online Course\, United States
CATEGORIES:Industry Professionals
ATTACH;FMTTYPE=image/jpeg:https://careerhub.massbioed.org/wp-content/uploads/2025/03/green-header-2-7GvhOB.tmp_.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251014T090000
DTEND;TZID=America/New_York:20251015T170000
DTSTAMP:20251014T224538Z
CREATED:20250718T221529Z
LAST-MODIFIED:20251014T224538Z
UID:3305-1760432400-1760547600@careerhub.massbioed.org
SUMMARY:Biotech Commercialization: From Approval to Access (NEW) – October 2025
DESCRIPTION:Members of LabOps Unite\, please register here.\nMembers of Bio CT\, please register here.\nPlease view the discount options for courses before registering here.\n\n\nMember Rate: $1\,275 \n\n\nNon-Member Rate: $1\,500 \n\n\nInterested in offering the training exclusively to a group of your employees? Email courses@massbioed.org to learn more.\nDescription \nThis advanced course explores the critical intersection of biotechnology\, business\, and regulatory frameworks\, equipping participants with the knowledge and strategies needed to successfully bring biotech innovations to market. Covering key areas such as regulatory approval pathways\, pricing and reimbursement dynamics\, market access\, and commercialization strategies\, this course provides a comprehensive roadmap for navigating the complexities of biotech product launch and market adoption. Through interactive lectures\, case studies\, and a hands-on capstone project\, participants will gain practical insights into market assessment\, go-to market planning\, strategic partnerships\, and financial feasibility.  \n\n\nDate & Time\nTuesday\, October 14th\, 2025\, 9:00 AM – 5:00 PM EST \nWednesday\, October 15th\, 2025\, 9:00 AM – 1:00 PM EST\n\n\n\n\nPlease plan to arrive at least 15 minutes before class starts. Class will start at 9:00 AM. We will have breaks in between. \nThis course will be held in-person. Breakfast and lunch will be provided at this all day workshop.  \nAgenda\nRegulatory Pathways & Market Assessment \n\nOverview of global regulatory frameworks (FDA\, EMA\, PMDA\, etc.)\nRole of Health Technology Assessment (HTA) bodies in market access\nMarket opportunity analysis: TAM\, SAM\, SOM\, and competitive landscape\nUnderstanding customer needs and decision-making processes\n\nCommercialization & Go-to-Market Strategy \n\nDeveloping a commercialization roadmap\nSales and distribution models for biotech innovations\nKey partnerships\, licensing\, and business development strategies\nMarketing\, branding\, and customer engagement for biotech products\n\nPricing\, Reimbursement & Financial Strategy \n\nPricing models\, reimbursement mechanisms\, and value-based agreements\nClinical indication sequencing and long-term pricing strategy\nFunding mechanisms: venture capital\, grants\, and partnerships\nFinancial feasibility and ROI evaluation for commercialization\n\nCapstone Project: Commercialization Plan & Presentation \n\nTeam-based development of a commercialization plan for a biotech product\nPresentation of strategy\, including regulatory approach\, financial model\, and market entry plan\nGroup feedback and expert insights\n\nInstructors\n\nJohn Tagliamonte\nChief Executive Officer\, Mellitus\n \nBusiness \n\n\nJohn Tagliamonte has more than 30 years of experience in executive leadership with responsibility for business development\, finance\, commercial and business operations\, strategic planning\, finance and legal functions with established and emerging public and private life sciences companies.  As the first Entrepreneur-in-Residence with MassBio\, he was responsible for forward-looking program content across the organization\, while helping to develop the next generation of biotech entrepreneurs. He currently serves on the business advisory boards of therapeutic startups WntRx\, Fractal\, MarkTx\, PhagePro and Tantu.  Previously he led business development at Juniper\, was Chief Business Officer of Oxyrane and held various executive business leadership roles at Anchor Therapeutics\, ImmunoGen and Johnson & Johnson\, as well as venture investing with Safeguard.  He began his career as a scientist at Dana-Farber Cancer Institute followed by global business unit management at Bio-Rad.  Mr. Tagliamonte received his M.B.A. from Boston College and his B.S. in molecular biology from Tufts University. \n\n\n\n\nAtul Deshpande\, Ph.D.\, MBA\nChief Strategy Officer\, Peptilogics \nBusiness \nAtul Deshpande is the Chief Strategy Officer at Peptilogics\, a clinical stage AI/ML driven peptide therapeutics company\, where he is responsible for corporate strategy and business development. Prior to that he was the Chief Executive Officer of IMMEDIATE Therapeutics\, a clinical stage biotech company dedicated to developing safe and effective therapeutic solutions to reduce heart muscle damage and prevent cardiac arrest in Acute Coronary Syndromes (ACS)\, the most common cause of death and morbidity across the world. Atul spent 3 years in China as the Head of Asia Pacific R&D strategy to bring the global portfolio to China with minimal drug lag. Before Sanofi\, Atul worked as a management consultant for 9 years on projects across the value chain of pharma. Atul holds a Ph.D. from UC Irvine in Neuroscience and a post-doc from UCLA.
URL:https://careerhub.massbioed.org/event/biotech-commercialization-from-approval-to-access-new-october-2025/
LOCATION:MassBioEd Office (The Link)\, 255 Main Street\, Cambridge\, MA\, 02142\, United States
CATEGORIES:Industry Professionals
ATTACH;FMTTYPE=image/jpeg:https://careerhub.massbioed.org/wp-content/uploads/2025/03/green-header-2-7GvhOB.tmp_.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251015T090000
DTEND;TZID=America/New_York:20251105T123000
DTSTAMP:20251016T000033Z
CREATED:20250807T174609Z
LAST-MODIFIED:20251016T000033Z
UID:3681-1760518800-1762345800@careerhub.massbioed.org
SUMMARY:Accelerated Leadership – Oct/Nov 2025
DESCRIPTION:Members of LabOps Unite\, please register here.\nMembers of Bio CT\, please register here.\nDeadline to Register: September 24\, 2025\nPlease view the discount options for courses before registering here.\n\n\nMember Rate: $1\,200 \n\n\nNon-Member Rate: $1\,320 \n\n\nInterested in offering the training exclusively to a group of your employees? Email courses@massbioed.org to learn more. \nDescription\n\n\nThe Accelerated Leadership Program provides leaders with critical leadership competencies to accelerate their performance in leading life sciences companies. Specifically\, the course will focus on leaders’ capabilities in areas of strategic planning and decision making\, influence\, collaboration\, and executive presence. The skills associated with the program\, when mastered\, can enable significant and strategic impact for a leader and their contributions to an organization. \n\n\n\n\n\n“I appreciated the balance of theory and practice\, for example the slides presented by the instructor was followed by team exercises. This strengthened comprehension of the topics and gave us a safe environment to practice such skills.”\n– Accelerated Leadership Attendee\, January 2022\n\nSchedule\n\nWednesday\, October 15th\, 2025\, 9:00 AM – 12:30 PM EST\nWednesday\, October 22th\, 2025\, 9:00 AM – 12:30 PM EST\nWednesday\, October 29th\, 2025\, 9:00 AM – 12:30 PM EST\nWednesday\, November 5th\, 2025\, 9:00 AM – 12:30 PM EST\n\nAgenda\nSession 1:\nCollaborative Influence\nExploring Skills & Knowledge to Motivate employees\nStrategies to Win Support and Acceptance\nCollaborative Relationships \n \nSession 2:\nStrategic Planning\nDecision-Making\nAnalyzing Problems & Opportunities\n \nSession 3 & 4:\nExecutive Presence\nDeveloping Influence\, Credibility & Authenticity as Presenters and Listeners\nInstructor\nRick Lyman\nFounder & President\, Executive Consulting and Coaching\nAs a consultant\, Rick has worked across Europe\, Asia\, South America\, and the U.S. and has served clients in a wide range of industries including: financial services\, technology\, healthcare\, retail\, biotech\, hospitality\, transportation\, telecommunications\, agriculture\, building supply\, and real estate.  Among those industries Rick has a successful track record of providing comprehensive talent management solutions that have helped to transform startups\, emerging market companies\, and mature organizations.\n \nRick was the Director of Organizational Development for Boston Scientific and responsible for designing and implementing talent management strategies that accelerated the competitive\, strategic advantage of the company. Rick has 30 years of experience leading organizational and executive development efforts for Cisco Systems\, Fidelity Investments\, and Bank of America. He developed a deep expertise in designing organizations\, developing talent\, and leading large scale transformations.  Most recently has been working as an executive coach for Harvard Business School and partnering with executives from around the world who attend the School’s Executive Education programs.\n \nRick graduated from Brown University with a BA and MA in English and with an MBA from Babson. Rick lives in Concord\, MA with his wife (Keri)\, two boys (Christopher and Benjamin)\, and two dogs who keep him in shape with daily long walks in the woods.  In his spare time\, he volunteers his consulting services to non-profit organizations and his mentoring to proteges around the country. 
URL:https://careerhub.massbioed.org/event/accelerated-leadership-oct-nov-2025/
LOCATION:Online Course\, United States
CATEGORIES:Industry Professionals
ATTACH;FMTTYPE=image/jpeg:https://careerhub.massbioed.org/wp-content/uploads/2025/03/green-header-2-7GvhOB.tmp_.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251016T090000
DTEND;TZID=America/New_York:20251016T160000
DTSTAMP:20251016T224726Z
CREATED:20250718T221529Z
LAST-MODIFIED:20251016T224726Z
UID:3306-1760605200-1760630400@careerhub.massbioed.org
SUMMARY:Transitioning to Leader – October 2025
DESCRIPTION:Members of LabOps Unite\, please register here.\nMembers of Bio CT\, please register here.\nPlease view the discount options for courses before registering here.\n\nMember Rate: $850\nNon Member Rate: $1\,025\n\nInterested in offering the training exclusively to a group of your employees? Email courses@massbioed.org to learn more. \nDescription\n\n\nTransitioning to Leader provides participants with a clear understanding of the leader-manager they aim to be and the essential skills and strategies to get them there. Approaches to effective communication and how to foster collaboration among teams (both remotely and in person) are discussed. Participants will also discuss the leader’s role in fostering employee engagement. \nDate and Time\nThursday\, October 16th\, 2025\, 9:00 AM – 4:00 PM EST \nPlease plan to arrive at least 15 minutes before class starts. Class will start at 9:00 AM. We will have breaks in between. \nThis course will be held in-person. Breakfast and lunch will be provided at this all day workshop. \nTopics\n\nTransitioning to Leader-Manager\nSetting Employees Up for Success\nLeader as Communicator\nFundamental Communication Skills and Responsibilities\nShaping Culture\nManager’s Role in Employee Engagement\n\nInstructor\nMatt Mirisola\nHuman Resources Consultant\n \nMatt has served as a leadership coach and consultant for over 20 years\, providing training to professionals at biotech and pharmaceutical companies. His expertise is in leadership development and coaching\, management and employee training\, and teambuilding facilitation. Most recently\, Matt served as Associate Director of Training and Development at Genetics Institute\, where he was responsible for developing and delivering training seminars on a variety of topics\, facilitating teambuilding and problem-solving meetings\, and employee coaching and development. Previously\, he worked alongside human resources leaders at General Electric. He began his career as a Military Intelligence Officer for the United States Army. Matt earned his Master of Public Policy & Management degree in Organizational Behavior at Yale School of Management and holds a Bachelor of Science degree in Engineering and Behavioral Sciences from the United States Military Academy at West Point.
URL:https://careerhub.massbioed.org/event/transitioning-to-leader-october-2025/
LOCATION:MassBioEd Office (The Link)\, 255 Main Street\, Cambridge\, MA\, 02142\, United States
CATEGORIES:Industry Professionals
ATTACH;FMTTYPE=image/jpeg:https://careerhub.massbioed.org/wp-content/uploads/2025/03/green-header-2-7GvhOB.tmp_.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251020T100000
DTEND;TZID=America/New_York:20251023T123000
DTSTAMP:20251020T195926Z
CREATED:20250620T000134Z
LAST-MODIFIED:20251020T195926Z
UID:2307-1760954400-1761222600@careerhub.massbioed.org
SUMMARY:Drug Development Pathways – October 2025
DESCRIPTION:Course ID: C-13314\nMembers of LabOps Unite\, please register here.\nMembers of Bio CT\, please register here.\n\n\nMember: $850 \n\n\nNon-Member: $1\,025 \n\n\nInterested in offering the training exclusively to a group of your employees? Email courses@massbioed.org to learn more. \nDescription\nIn this interactive\, hands-on workshop\, participants will learn the basics of drug development. Starting with identifying a target or indication in the discovery phase\, the de-risking necessary before entering the manufacturing and regulatory environment\, the pre-clinical and clinical phases leading to regulatory approval. You will learn these different phases\, why it is important to mitigate risk therefore minimize spend allowing companies to progress and the regulatory landscape necessary for approval. Included in the discussions will be the variety of vendors and roles necessary and their interdependent relationships and the need for teamwork. The post-approval and marketing process will be discussed especially as it relates to study design\, regulations\, and alliances. The course will provide you the history of US FDA regulations providing a framework as to why certain guidance’s were implemented. \n\nSchedule\n1. Monday\, October 20\, 2025\, 10:00 AM – 12:30 PM   \n2. Tuesday\, October 21\, 2025\, 10:00 AM – 12:30 PM   \n3. Thursday\, October 23\, 2025\, 10:00 AM – 12:30 PM   \nAgenda\nSession 1: Strategy and Early Development\n• The history of regulation and how to navigate\n• Discovery phase to selecting a candidate\n• Developing the strategy and lead indication\n• Building quality into your plans \nSession 2: The Regulatory Process and Pre-Clinical/Clinical Development\n• IND and alternative strategies to First in Human/Patient\n• Pre-clinical plans\n• The phases of clinical trials\n• Pharmacovigilance \nSession 3: The Approval Process and Post-Marketing\n• Business considerations\n• Regulatory submissions and meetings with authorities\n• Marketing authorities and post-approval commitments\n• Wrap up and Q&A \n \nInstructor\nCatherine Mesner\nBio-Pharma Advisor \nCatherine brings over 30 years of experience leading drug development programs across biotech and pharma\, with senior roles at Eli Lilly\, Pfizer\, and Checkmate Pharmaceuticals. She has overseen clinical strategies from discovery through Phase 2 trials\, managed $250M+ R&D budgets\, and guided multiple products to regulatory approval. Now a strategic advisor to emerging biotech start-ups\, Catherine offers practical insights shaped by decades of hands-on experience. 
URL:https://careerhub.massbioed.org/event/drug-development-pathways-september-2025/
LOCATION:Online Course\, United States
CATEGORIES:Industry Professionals
ATTACH;FMTTYPE=image/jpeg:https://careerhub.massbioed.org/wp-content/uploads/2025/03/green-header-2-7GvhOB.tmp_.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251028T130000
DTEND;TZID=America/New_York:20251031T153000
DTSTAMP:20251028T120036Z
CREATED:20250802T091634Z
LAST-MODIFIED:20251028T120036Z
UID:3575-1761656400-1761924600@careerhub.massbioed.org
SUMMARY:Supply Chain Management – October 2025
DESCRIPTION:Members of LabOps Unite\, please register here.\nMembers of Bio CT\, please register here.\nPlease view the discount options for courses before registering here.\n\n\nMember Rate: $850 \n\n\nNon-Member Rate: $970 \n\n\nDescription\nGiven the current environment of global supply chain challenges affecting daily lives from retail to technology\, the biotechnology industry is no different in experiencing raw materials delays and shipping drug substance for further processing before our therapies get to our patients. This course is recommended for Supply Chain staff\, R&D Managers\, and anyone with an interest in how supply chains work in the Biopharma industry. \nSchedule\n\nMonday\, October 27th\, 2025\, 1:00 PM – 3:30 PM EST\nThursday\, October 30th\, 2025\, 1:00 PM – 3:30 PM EST\nFriday\, October 31st\, 2025\, 1:00 PM – 3:30 PM EST\n\nAgenda\nSession 1: \n\nSupply Chain Overview\nCompliance Considerations and Requirements\nWhat is GMP?\n\nSession 2: \n\nTech Transfer Process & Operations\nClinical and Commercial Manufacturing\nOperations Support\nMaterial Flow for Chemicals and Raw Materials\n\nSession 3: \n\nRaw Material Challenges\nCOVID and Post COVID Reality\nEmerging New Technologies\n\nInstructors\nNazma M. Rosado\, MAOL\, PMP\, CMQ/OE\nPrincipal Consultant\, Avion Consulting \nNazma has over 25 years of experience in the leadership\, team and organizational development spaces. She served as the Global Head of Organizational Development at several large Pharma companies prior to her transition to consulting. She works with senior leaders to help change behaviors that shape the company’s culture and increase employee engagement\, inclusion\, and belonging. Nazma has a passion for people and a strong desire to make the workplace more diverse\, engaging\, and productive by choice. She is an experienced executive coach and has helped senior leaders develop their staff\, teams\, and selves. \nNazma is a versatile and results-driven consultant with demonstrated experience in executive coaching\, team development\, business process optimization and change management practices. She is highly skilled at training strategy design/delivery\, change management needs identification\, and creating cultures that value diversity\, equity\, and inclusion. She is an analytical and strategic thinker who develops scalable\, repeatable\, and sustainable strategies and results; strategically utilizes instructor-led\, eLearning and web-based curricula to deliver maximum results and uses analytics to determine ROI. \nNazma has a B.A. in Neuroscience and a B.A. in Psychology from Colgate University and a M.A. in Organizational Leadership from Gonzaga University. Nazma has earned many professional certifications including Project Management Professional (PMP)\, Six Sigma Green Belt (6σ)\, and Certifications in Change Management from APMG and Prosci.
URL:https://careerhub.massbioed.org/event/supply-chain-management-october-2025/
LOCATION:Online Course\, United States
CATEGORIES:Industry Professionals
ATTACH;FMTTYPE=image/jpeg:https://careerhub.massbioed.org/wp-content/uploads/2025/03/green-header-2-7GvhOB.tmp_.jpg
END:VEVENT
END:VCALENDAR